Amanda N. Raad

Partner

Amanda Raad serves as a trusted advisor to clients seeking wide-ranging counsel on global and cross-border risk. Qualified in the United States and as a Solicitor in England & Wales, she leverages her extensive knowledge and experience of these active enforcement regimes to help clients navigate risk from both jurisdictions. In summary of her practice, clients note she “counsels and advises with intelligence and caution and has tremendous credibility with regulators.” Amanda was named one of the “top ten legal practitioners” in the recent Financial Times Innovative Lawyers report.

Health care enterprises, life sciences companies, private equity firms, sovereign investors and organizations involved in corporate transactions are among the clients that turn to Amanda for advice on specific U.S. and U.K. enforcement matters and related investigations, as well as for guidance in creating compliant cultures. Clients describe her as “incredibly tactical,” and note that her “particular strength is providing practical, actionable legal advice.”

As founder of Ropes & Gray’s Data and Behavioral Science Initiative, Amanda is a leader in the use of data analytics and behavioral science to help organizations establish compliance-driven cultures, effectively manage global risk, and implement remediation solutions as necessary. Leveraging this unique approach to compliance, Amanda also launched R&G’s Insights Lab, an innovative, full service legal consulting group – and the industry’s first-ever analytics and behavioural science offering. As co-leader, Amanda works closely with a multidisciplinary team of internal and external collaborators to design creative, data-driven and human-centered solutions for our clients’ most significant legal and business challenges. Her work addresses the full risk spectrum, encompassing:

Financial fraud
Corruption
Sanctions
Money laundering
Cyber and data privacy risk
Antitrust compliance
Sexual misconduct

In light of the financial devastation caused by the COVID-19 crisis, Amanda has been partnering with clients to reassess their risk and help them take proactive steps to ensure the effectiveness of their business solutions in a changing and challenging environment.

Global co-leader of Ropes & Gray’s anti-corruption and international risk practice, Amanda also co-founded the firm’s fraud in times of crisis task force, as well as the firm’s global health care compliance initiative. She publishes and speaks frequently on cross-border challenges in the areas of corporate crime and investigations, including those associated with sexual misconduct. She is a regular contributor to GIR’s “The Practitioner’s Guide to Global Investigations,” and serves as a committee member for the American Bar Association’s Women’s White Collar Defense Association and the U.K.’s Fraud Lawyers Association. Amanda is listed in GIR’s Women in Investigations 2018, Chambers UK, The Legal 500 UK and New York Super Lawyers.

Deeply committed to pro bono work, Amanda co-chairs Ropes & Gray’s pro bono committee. Since 2016, she has served on the board of Lawyers Without Borders.

Experience

Defended international pharmaceutical and medical device companies in cross-border corruption investigations, resulting in favorable outcomes

Designed and implemented pre-acquisition international risk diligence protocols for multiple private equity firms and assisted with post-acquisition implementation of enhanced compliance controls. Ropes & Gray and an American multinational private equity firm recently received the “Best Client-Law Firm Team” at the American Lawyer’s Annual Industry Awards

Led anti-corruption and international risk assessments in the private equity, pharmaceutical and energy sectors, resulting in the development and implementation of enhanced compliance controls

Counsel to several finance executives in international anti-money laundering and OFAC investigations

Counsel to senior executive in international criminal investigation of alleged collusion among banks in the setting of LIBOR and other benchmark interest rates

Participated in Lawyers Without Borders Kenya training of magistrates, prosecutors, and investigating officers of how to better investigate and prosecute wildlife crime

Partnered with Lawyers Without Borders to evaluate potential supply chain training opportunities to identify and mitigate human trafficking

Advised clients on the Modern Slavery Act and related obligations

Led a team representing inmates in New York City jails in a class action against the City of New York for guard brutality

Served as lead counsel in a political asylum case, presenting on behalf of the National Immigrant Justice Center, securing a positive outcome for the victim

Disclaimer

Publications

Named one of the “top ten legal practitioners” in Financial Times Innovative Lawyers (2020)

Who’s Who Legal Investigations (2020)

Individually recognized by Chambers UK for her expertise for the ‘Financial Crime: Corporates – London’ category (2021)

Individually recognized by Legal 500 UK for the ‘Regulatory Investigations and Corporate Crime’ and ‘Fraud: White-Collar Crime’ categories in 2021

Global Investigations Review 100 (2020)—ranked in the top 20 of the annual guide to the world’s leading investigations practices

Global Investigations Review’s ‘Women in Investigations’ (2018)

New York Super Lawyers Rising Star (2014-2020)

UK Legal 500 (2014-2021)

Recipient - The Legal Aid Society, Society’s 2014 Pro Bono Publico Awards

Presentations

Publications

Co-author, “Individuals in Cross-Border Investigations or Proceedings: The US Perspective,” The Practitioner’s Guide to Global Investigations (2021)

Co-author, “The Use of Behavioural Science in Compliance Monitoring, AML and Anticorruption,” Lissack and Horlick on Bribery and Corruption: Third Edition (October 10, 2020)

Co-author, “Culture, Compliance and Crisis,” Global Investigations Review (May 5, 2020)

Quoted, “Best Practices for Fund Managers to Investigate and Document Employee Discipline (Part Two of Three),” The Private Equity Law Report (March 24, 2020)

Quoted, “Components of an Employee Discipline Framework to Foster Predictability Amidst Inconsistent Laws (Part One of Three),” The Private Equity Law Report (March 17, 2020)

Quoted, “Compliance Lessons From the Airbus Settlement,” The Anti-Corruption Report (March 4, 2020)

Quoted, “City faces up to ‘dirty money’ through suspicious activity reports,” The Times (November 21, 2019)

Quoted, “In New Guidance, SFO Outlines Internal Investigation Expectations,” The Anti-Corruption Report (November 13, 2019)

Quoted, “In New Guidance, SFO Indicates It Wants Companies to Waive Privilege,” The Anti-Corruption Report (October 16, 2019)

Quoted, “Damage Control,” Real Deals (July 18, 2019)

Co-author, “Managing Corruption Risks Facing Healthcare Companies in Eastern Europe,” The Anti-Corruption Report (June 12, 2019)

Co-author, “Global Anti-Money Laundering: Investigations and Compliance Trends in the Fintech Era,” Bloomberg Law (June 12, 2019)

Co-author, “DOJ commentary underscores importance of pre-acquisition diligence,” International Law Office Corporate Finance/M&A Newsletter (May 15, 2019)

Co-author, “Self-Reporting to the Authorities and Other Disclosure Obligations: The US Perspective,” The Practitioner’s Guide to Global Investigations, Third Edition (2019)

Co-author, “Self-Reporting to the Authorities and Other Disclosure Obligations: The UK Perspective,” The Practitioner’s Guide to Global Investigations, Third Edition (2019)

Quoted, “What Does a 'Bigger and Stronger' SFO Mean for Companies?,” The Anti-Corruption Report (November 28, 2018)

Quoted, “Behavioral Scientists Joining Risk Assessment Teams,” The Wall Street Journal (October 25, 2018)

Co-author, “Common Sense Prevails in the UK’s Battle over Legal Professional Privilege,” Expert Witness Journal (Autumn 2018)

Co-author, “Four Takeaways From the U.K.’s ENRC Privilege Decision,” The Anti-Corruption Report (October 17, 2018)

Quoted, “Real estate’s anti-corruption crusade,” PERE (September 2018)

Co-author, “The DOJ’s Corporate Enforcement Policy: An upgraded Pilot Program,” The Practitioner’s Guide to Global Investigations (July 2018)

Quoted, “Beam Suntory Is the Latest Victim of the Beverages Industry in India,” The Anti-Corruption Report (July 25, 2018)

Quoted, “Can New SFO Chief Recharge Agency?,” The Wall Street Journal (June 5, 2018)

Co-author, “Compliance 2.0: The Role of Data and Behavioral Science in Risk Management,” The Anti-Corruption Report (May 16, 2018)

Co-author, “Creating a Successful Global Compliance Programme,” Pharmaceutical Market Europe (PME) magazine (May 9, 2018)

Participant, “Podcast - Risk Management: Troubleshooting & Problem Solving,” JD Supra (April 23, 2018)

Quoted, “Crafting and Delivering Effective Upjohn Warning,” The Anti-Corruption Report (April 18, 2018)

Author, “Risk Mitigation & Management: Bringing a Compliance Program to Life,” Lexology (April 11, 2018)

Co-author, “U.S. Legislation requires enhancements to modern slavery compliance procedures to address North Korean labour risks,” Trade Security Journal (March 2, 2018)

Quoted, “Best Practices for Fund Managers to Ensure a Fair Process When Disciplining Employees (Part Three of Three),” The Hedge Fund Law Report (February 22, 2018)

Quoted, “Best Practices for Fund Managers When Investigating and Documenting Employee Discipline (Part Two of Three),” The Hedge Fund Law Report (February 15, 2018)

Quoted, “Havens in hell: will EU tax evasion plans hit too hard?,” fDi magazine (February 15, 2018)

Quoted, “Best Practices for Fund Managers to Develop an Employee Discipline Framework That Fosters Predictability in the Face of Inconsistent Laws (Part One of Three),” The Hedge Fund Law Report (February 8, 2018)

Quoted, “High Court sides with RBS in litigation privilege dispute,” Global Investigations Review (February 6, 2018)

Quoted, “UK financial crime: NECC to launch; SFO director to quit,” StrategicRISK (January 24, 2018)

Co-Authored, “Self-Reporting to the Authorities and Other Disclosure Obligations: The UK Perspective,” Global Investigations Review (December 2017)

Quoted, “The Morning Risk Report: U.K. Enlists Behavioral Sciences to Fight Corruption,” The Wall Street Journal (December 19, 2017)

Quoted, “Employee Discipline for Anti-Corruption Issues: Due Process for a Just and Effective System (Part Three of Three),” The Anti-Corruption Report (November 29, 2017)

Quoted, “Employee Discipline for Anti-Corruption Issues: Predictability and Consistency in the Face of Inconsistent Laws (Part One of Three),” The Anti-Corruption Report (November 1, 2017)

Author, “Multinationals must be leaders, not followers, with risk management,” The Times (The Brief) (October 25, 2017)

Quoted, “China, Brazil and Russia named by healthcare companies as the riskiest markets for compliance and regulation,” International Pharmaceutical Industry (October 23, 2017)

Quoted, “Investors name UK as world’s second riskiest market for compliance and regulation,” Private Equity Wire (September 29, 2017)

Quoted, “China is ‘most riskiest market’ for compliance, regulation – study,”KYC360 (September 29, 2017)

Quoted, “UK named second riskiest market amid regulatory pressures,” Investment Week (September 28, 2017)

Quoted, “High Fines Make Working in U.K. Risky, Asset Managers Say,” Institutional Investor (September 28, 2017)

Quoted, “Finance and tech firms say UK riskiest market after China,” Financial News (September 28, 2017)

Quoted, “The DPA Learning Curve,” Commercial Dispute Resolution (August 22, 2017)

Co-author, “No Need to Overreact: Protecting Privilege in the U.S. and U.K. After the ENRC Decision,” The FCPA Report (June 21, 2017)

Quoted, “No winners in High Court's privilege ruling,” The Times (The Brief) (May 17, 2017)

Author, “Let’s Share our Expertise to Right Global Wrongs,” The Times (May 4, 2017)

Co-author, “What new DOJ guidance means for compliance,” Compliance Reporter (April 11, 2017)

Co-author, “DOJ’s New Guidance for Compliance Programs,” Harvard Law School Forum on Corporate Governance and Financial Regulation (March 19, 2017)

Co-author, “How The GDPR Will Impact Life Sciences And Health Care,” Law360 (February 21, 2017)

Co-author, “Self-Reporting to the Authorities and Other Disclosure Obligations: The UK Perspective,” Global Investigations Review’s The Practitioner’s Guide to Global Investigations (January 2017)

Co-author, “Self-Reporting to the Authorities and Other Disclosure Obligations: The US Perspective,” Global Investigations Review’s The Practitioner’s Guide to Global Investigations (January 2017)

Q&A, “In Real Estate, the Corruption Risks Can Be in the Details: Attorney,” ACAMS Money Laundering (Aug. 31, 2016)

Co-author, “Practice Note: How to handle real estate compliance risks,” The FCPA Blog (August, 25, 2016)

Co-author, “Compliance Alert: Enforcement hammer falls on real estate,” The FCPA Blog (August 23, 2016)

Co-author, “Reps & Warranties Insurance From A Compliance Perspective,” Law360 (July 28, 2016)

Co-author, “And breathe … The SFO on Privilege,” Fraud Intelligence (March 14, 2016)

Co-author, “From Corruption To AML: The Future Of Chinese Enforcement,” Law360 (March 8, 2016)

Co-author, “Standard Bank PLC: First U.K. Deferred Prosecution Agreement and Settlement with the SEC,” Ropes & Gray Alert (January 6, 2016)

Co-author, “Avoiding minefields: managing cross-border investigations,” Financier Worldwide (July 2015)

Co-author, “Mind your step! Avoiding the legal pitfalls of being an operating partner,” Operating Partner in Private Equity, Volume 2 (Private Equity International, June 2015)

Co-author, “The UK Anti-Corruption Plan: what impact will it have?,” Global Investigations Review (March 9, 2015)

Quoted, “Forceful anti-corruption enforcement making bribery more bane than boon for companies,” Association of Certified Financial Crime Specialists, (December 2014)

Co-author, “Tips for an Effective Anticorruption Monitoring Program,” Corporate Counsel (September 5, 2014)

Co-author, “Busting Bribery Post-Acquisition,” Private Equity International (August 20, 2014)

Co-author, “Minimising Corruption Risks in African Investment Opportunities,”Financier Worldwide (July 2014)

Co-author, “Medical Industries Under the Anticorruption Lens,” Corporate Counsel (April 15, 2013)

Co-author, "How To Implement Conflict Minerals Rule Requirements," Law360 (September 26, 2012)

Co-author, "The Latest FCPA Target: Private Fund Advisers," Law360 (May 11, 2012)

Author, “Global Anti-Corruption Compliance: The One Stop Shop?” Winter 2012 Criminal Justice Section Newsletter (2012)

Co-author, “A Headline Shift, Not a Priority Shift: The Government Expands Its Second Front in the War on Health Care Fraud,” Bloomberg Law Reports (December 16, 2011)

Co-author, "Facing FCPA Charges In Foreign Countries," Law360 (January 2012)

Co-author, “What Every Private Equity Professional Should Know About the Expanded Scope of Global Anticorruption Enforcement,” The Journal of Private Equity (Fall 2010)

Co-author, "The Modern Realities of the FCPA," SecuritiesLaw360 (February 19, 2009)

Presentations

Panelist, “Behavioral Science: A Tool for Effective Compliance,” 38^th Cambridge International Symposium on Economic Crime (September 2021)

Speaker, “A View of Compliance in U.K. and U.S. Practice,” ComplianceNet 2021 Conference Programme (June 28, 2021)

Moderator, “US DOJ’s Evaluation of Corporate Compliance,” International Society of Healthcare Ethics and Compliance Professionals (ETHICS) -- Virtual 14th International Pharmaceutical and Medical Device Ethics & Compliance Congress (June 14-17, 2021)

Speaker, “Ethics, FCPA & Disclosure Process in an International Environment,” International Operations Accounting Conference (April 22-23, 2021)

Speaker, FTI’s Innovative Lawyers North America Roundtable (March 25, 2021)

Speaker, “Cambridge Union Event – Women Leading the Commercial World” (February 22, 2021)

“2021 Global Anti-Corruption Update,” Ropes & Gray Podcast (January 14, 2021)

Panelist, “Internal and Cross Border Investigations—Evaluating Corporate Compliance in the Context of DOJ Updated Guidance,” Association of Corporate Investigations, (November 18, 2020)

“Women @ RopesTalk: Conversation with Louise Dumican, The Carlyle Group,” Ropes & Gray Podcast (October 14, 2020)

Speaker, “Ethical Leadership Fireside Chat and Q&A” (September 24, 2020)

“R&G Insights Lab—Culture & Compliance Chronicles: Using Data Ethically,” Ropes & Gray Podcast (September 14, 2020)

Panelist, “The Impact of a Global Crisis on Anti-Bribery Compliance,” Ropes & Gray Joint Webinar with Transparency International (September 3, 2020)

Speaker, “Behavioral Science and Data Analytics – FSU Law Class Discussion” (August 19, 2020)

“Culture & Compliance Chronicles: Building Relationships & Making Connections,” Ropes & Gray Podcast (July 16, 2020)

“Insiders’ Perspectives on the Ins and Outs of the 2020 DOJ FCPA Guide: A Conversation with Ropes & Gray’s Anti-Corruption and International Risk Leaders,” Ropes & Gray Podcast (July 15, 2020)

Speaker, “Behavioral Science and Innovative Thinking in Times of Crisis,” Presentation (July 9, 2020)

“Culture & Compliance Chronicles: Effective Remediation,” Ropes & Gray Podcast (July 1, 2020)

Panelist, “The Grey Zone—A Virtual Panel Discussion” (June 23, 2020)

“Culture & Compliance Chronicles: Measuring Culture,” Ropes & Gray Podcast (June 15, 2020)

“COVID-19: Global Health Care Compliance: Managing Compliance Issues and Process Changes Related to the Pandemic,” Ropes & Gray Podcast (June 4, 2020)

“Culture & Compliance Chronicles: Culture in Times of Crisis,” Ropes & Gray Podcast (June 1, 2020)

Speaker, "HCCA/SCCE Webinar - Can A Risk Based Approach to Compliance Miss Real-World Risk? Multiple Perspectives on Compliance and Workplace Challenges During Times of Crisis,” Ropes & Gray (May 20, 2020)

“Culture & Compliance Chronicles: Incorporating Behavioral Science in Audit & Monitoring,” Ropes & Gray Podcast (April 28, 2020)

“Culture & Compliance Chronicles: Behavioral Science – The Audit & Monitoring Perspective,” Ropes & Gray Podcast (April 1, 2020)

Keynote Speaker and Panelist, “Lawyers Without Borders – 6th Annual Rule of Law Innovation Challenge” (March 30, 2020)

“Applying Behavioral Science to Compliance – A Conversation with Richard Bistrong, Front-Line Anti-Bribery LLC,” Ropes & Gray Podcast (December 18, 2019)

Speaker, “Senior Executive Turned Cooperating Witness, and now Compliance Professional - A Ropes & Gray fireside chat with Richard Bistrong “ ACi Symposium, London (November 14, 2019)

Panelist, “Sexual Misconduct in the Work Place and How to Ensure Better Protection of Rights, Investigations of Issues, and Encourage Speak Up,” C5’s Women Leaders in Life Sciences Law, Amsterdam (June 2018)

Panelist, “Governance of International Sport,” MIT Sloan Sports Analytics Conference (March 2017)

Panelist, “Shopping for a business coach: Is it worth the spend?,” Women in White Collar Crime Luncheon & Panel Discussion, K&L Gates (October 2016)

Speaker, “Prevention is Better Than Cure - The Importance of Compliance Procedures Prior to an Acquisition,” Corporate M&A Summit (October 2016)

Panelist, “The role and responsibilities of monitors,” Cambridge Economic Crime Symposium (September 2016)

Speaker, “Fourth International White Collar Crime Institute,” (October 2015)

Global Investigations Review “Internal Investigations Roundtable,” (June 2015)

Presenter, “Successor Liability under the FCPA and Bribery Act,” Bloomberg Webinar (June 2015)

Moderator, “European Compliance & Ethics Institute Conflicting Compliance: When Foreign Laws are at odds with Anti-Corruption Compliance under the FCPA and UK Bribery Act,” European Compliance & Ethics Institute (March 2015)

Panelist, “How to Build Effective Internal Financial Controls to Meet Government Expectations and Minimize Exposure to Books and Records Violations,” Anti-Corruption Experts Conference (October 2013)

Panelist, “Recent Trends and Updates on Anti-Corruption, OFAC/AML and Global Financial Investigations,” NYSBA Symposium on the Challenges of Multijurisdictional Investigations and Enforcement (October 2013)

Presenter, “Foreign Corrupt Practices Act - FCPA Basics” (December 2012)

Presenter, “Anti-Corruption Laws Overview & Key Risk Areas,” Pfizer Legal Alliance Continuing Education (PLACE) (April 2012)

Presenter, “The FCPA in the Private Equity Market” (August 2010)

Amanda N. Raad

Partner

Amanda N. Raad

Partner

Contact

Practices

Industries

News

Financial Times Honors R&G Insights Lab at “Innovative Lawyers” Awards

Publications

Education

Admissions / Qualifications

Qualifications

Court Admissions

Clerkships

Memberships & Affiliations

Events

Data-Driven and Human-Centered Approaches to Risk Management

Experience

Disclaimer

Publications

Presentations

Publications

Presentations